One of the RNA splicing factor, RNA splicing factor serine/arginine repetitive matrix 4, SRRM4, was recently identified as a strong stimulator of adenocarcinoma cells to express NEPC biomarkers under androgen receptor pathway inhibition. The gene discussed is AR; the disease is adenocarcinoma.